학술논문

LOVASTATIN THERAPY APPEARS TO REDUCE THE INVIVO AFFINITY OF LOW-DENSITY LIPOPROTEINS (LDL) FOR THE LDL RECEPTOR
Document Type
Journal
Source
ARTERIOSCLEROSIS; SEP-OCT 1989, 9 5, pA708-pA708, 1p.
Subject
Language
English
ISSN
02765047